Academic
Publications
Definitive postoperative irradiation of bile duct carcinoma with charged particles and/or photons

Definitive postoperative irradiation of bile duct carcinoma with charged particles and/or photons,10.1016/0360-3016(93)90423-S,International Journal o

Definitive postoperative irradiation of bile duct carcinoma with charged particles and/or photons   (Citations: 14)
BibTex | RIS | RefWorks Download
The purpose was to determine the rates of survival and local control in patients with bile duct adenocarcinomas treated with post-operative photons and/or charged particles. A retrospective study was performed analyzing all patients with bile duct adenocarcinomas who received radiotherapy through the University of California San Francisco and at Lawrence Berkeley Laboratory between 1977 and 1987, a total of 62 patients. University of California San Francisco patients received photon therapy (median dose 5400 cGy), and Lawrence Berkeley Laboratory patients were treated with the charged particles helium and/or neon (median dose 6000 cGyE). Forty-eight patients were treated post-operatively with curative intent, 30 with photons and 18 with particles. Thirty-six patients in the study had gross residual disease; none had microscopically negative margins. The overall two-year actuarial survival was 28%: 44% for particle-treated patients and 18% for patients treated with photons ([ital p] = .048). Median actuarial survival was 23 months in particle patients and 12 months in photon patients. Local control was also improved, though less significantly, in patients treated with particles (median disease-free survival 20 months vs. 4.5 months, [ital p] = .054). A univariate and multivariate analysis was performed and revealed that only extent of residual disease predicted local failure and overall survival; no other prognostic factors were identified. Compared to conventional photon radiotherapy, treatment with post-operative charged particle irradiation at Lawrence Berkeley laboratory appeared to offer a survival advantage in this non-randomized series. Additional investigation into protection of surrounding normal tissue with better dose localization through the use of charged particles is planned.
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...A retrospective study by Schoenthaler et al. [21] was performed, including all patients with bile duct adenocarcinoma who received radiotherapy at the University of Cali- 47...

    J. R. Castro. Results of heavy ion radiotherapy

Sort by: